Skip to main content

Advertisement

Log in

Polycomb Group Oncogene RING1 is Over-expressed in Non-Small Cell Lung Cancer

  • Research
  • Published:
Pathology & Oncology Research

Abstract

Ring finger protein 1 (RING1) have recently been reported to be related to aggressive tumor features in Prostate Cancer and urothelial carcinoma of the bladder. However, the role of RING1 in non-small-cell lung cancer (NSCLC) tumorigenesis has never been elucidated. So we aimed at investigating the potential role of RING1 in NSCLC. RING1 expression was evaluated by Immunoblot in 8 paired fresh lung cancer tissues and immunohistochemistry on 69 paraffin-embedded sections from 2006 to 2009. Furthermore, flow-cytometry and RNA interference were performed to analyse the role of RING1 in A549 cells. We showed that the expression level of RING1 was significant increased in lung cancer as compared with the adjacent normal tissue. High expression level of RING1 was associated with TNM stage (P = 0.013), and RING1 was positively related with proliferation marker Ki67 (P < 0.05). Moreover, RING1 knockdown induces growth suppression of human lung cancer cells through G1/S cell cycle phase arrest in vitro. Kaplan–Meier survival curves showed that high expression level of RING1 was associated with poor prognosis (P = 0.03). On the basis of these results, we suggested that RING1 protein expression may be a favorable independent prognostic parameter for non-small cell lung cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

NSCLC:

Non-small cell lung cancer

PcG:

Poly-comb group

CDK2:

Cyclin-dependent kinase 2

GWAS:

Genome-wide association studies

References

  1. Buchenau P, Hodgson J, Strutt H, Arndt-Jovin DJ (1998) The distribution of poly-comb-group proteins during cell division and development in Drosophila embryos: impact on models for silencing. J Cell Biol 141(2):469–481

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Caldas C, Aparicio S (1999) Cell memory and cancer–the story of the trithorax and Poly-comb group genes. Cancer Metastasis Rev 18(2):313–329

    Article  CAS  PubMed  Google Scholar 

  3. Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, Tempst P et al (2002) Role of histone H3 lysine 27 methylation in Poly-comb-group silencing. Science 298(5595):1039–1043

    Article  CAS  PubMed  Google Scholar 

  4. Cao W, Ribeiro Rde O, Liu D, Saintigny P, Xia R, Xue Y et al (2012) EZH2 promotes malignant behaviors via cell cycle dysregulation and its mRNA level associates with prognosis of patient with non-small cell lung cancer. PLoS One 7(12):e52984

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Cooper CS, Foster CS (2009) Concepts of epigenetics in prostate cancer development. Br J Cancer 100(2):240–245

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Czermin B, Melfi R, McCabe D, Seitz V, Imhof A, Pirrotta V (2002) Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal Poly-comb sites. Cell 111(2):185–196

    Article  CAS  PubMed  Google Scholar 

  7. Dimri GP, Martinez JL, Jacobs JJ, Keblusek P, Itahana K, Van Lohuizen M et al (2002) The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Cancer Res 62(16):4736–4745

    CAS  PubMed  Google Scholar 

  8. Ferraiuolo MA, Rousseau M, Miyamoto C, Shenker S, Wang XQ, Nadler M et al (2010) The three-dimensional architecture of Hox cluster silencing. Nucleic Acids Res 38(21):7472–7484

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Fussbroich B, Wagener N, Macher-Goeppinger S, Benner A, Falth M, Sultmann H et al (2011) EZH2 depletion blocks the proliferation of colon cancer cells. PLoS One 6(7):e21651

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Goebl MG (1991) The bmi-1 and mel-18 gene products define a new family of DNA-binding proteins involved in cell proliferation and tumorigenesis. Cell 66(4):623

    Article  CAS  PubMed  Google Scholar 

  11. Hinz S, Kempkensteffen C, Christoph F, Krause H, Schrader M, Schostak M et al (2008) Expression parameters of the poly-comb group proteins BMI1, SUZ12, RING1 and CBX7 in urothelial carcinoma of the bladder and their prognostic relevance. Tumour Biol 29(5):323–329

    Article  CAS  PubMed  Google Scholar 

  12. Jacobs JJ, Scheijen B, Voncken JW, Kieboom K, Berns A, van Lohuizen M (1999) Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev 13(20):2678–2690

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60(5):277–300

    Article  PubMed  Google Scholar 

  14. Ke Q, Ji J, Cheng C, Zhang Y, Lu M, Wang Y et al (2009) Expression and prognostic role of Spy1 as a novel cell cycle protein in hepatocellular carcinoma. Exp Mol Pathol 87(3):167–172

    Article  CAS  PubMed  Google Scholar 

  15. Kerr KM (2013) Clinical relevance of the new IASLC/ERS/ATS adenocarcinoma classification. J Clin Pathol 66(10):832–8

    Article  PubMed  Google Scholar 

  16. Kovalchuk O, Tryndyak VP, Montgomery B, Boyko A, Kutanzi K, Zemp F et al (2007) Estrogen-induced rat breast carcinogenesis is characterized by alterations in DNA methylation, histone modifications and aberrant micro-RNA expression. Cell Cycle 6(16):2010–2018

    Article  CAS  PubMed  Google Scholar 

  17. Li H, Bitler BG, Vathipadiekal V, Maradeo ME, Slifker M, Creasy CL et al (2012) ALDH1A1 is a novel EZH2 target gene in epithelial ovarian cancer identified by genome-wide approaches. Cancer Prev Res (Phila) 5(3):484–491

    Article  CAS  Google Scholar 

  18. Li Z, Qu L, Dong Q, Huang B, Li H, Tang Z et al (2012) Over-expression of CARMA3 in non-small-cell lung cancer is linked for tumor progression. PLoS One 7(5):e36903

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Lu, C., Liu, G., Cui, X., Zhang, J., Wei, L., Wang, Y., et al. (2013). Expression of SGTA Correlates with Prognosis and Tumor Cell Proliferation in Human Hepatocellular Carcinoma. Pathol Oncol Res

  20. Mathers CD, Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3(11):e442

    Article  PubMed Central  PubMed  Google Scholar 

  21. Qin H, Wang J, Liang Y, Taniguchi Y, Tanigaki K, Han H (2004) RING1 inhibits transactivation of RBP-J by Notch through interaction with LIM protein KyoT2. Nucleic Acids Res 32(4):1492–1501

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Raaphorst FM, Meijer CJ, Fieret E, Blokzijl T, Mommers E, Buerger H et al (2003) Poorly differentiated breast carcinoma is associated with increased expression of the human poly-comb group EZH2 gene. Neoplasia 5(6):481–488

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Raaphorst FM, Vermeer M, Fieret E, Blokzijl T, Dukers D, Sewalt RG et al (2004) Site-specific expression of poly-comb-group genes encoding the HPC-HPH/PRC1 complex in clinically defined primary nodal and cutaneous large B-cell lymphomas. Am J Pathol 164(2):533–542

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. Satijn DP, Otte AP (1999) RING1 interacts with multiple Poly-comb-group proteins and displays tumorigenic activity. Mol Cell Biol 19(1):57–68

    CAS  PubMed Central  PubMed  Google Scholar 

  25. Satijn DP, Gunster MJ, van der Vlag J, Hamer KM, Schul W, Alkema MJ et al (1997) RING1 is associated with the poly-comb group protein complex and acts as a transcriptional repressor. Mol Cell Biol 17(7):4105–4113

    CAS  PubMed Central  PubMed  Google Scholar 

  26. Satijn DP, Olson DJ, van der Vlag J, Hamer KM, Lambrechts C, Masselink H et al (1997) Interference with the expression of a novel human poly-comb protein, hPc2, results in cellular transformation and apoptosis. Mol Cell Biol 17(10):6076–6086

    CAS  PubMed Central  PubMed  Google Scholar 

  27. Shin YJ, Kim JH (2012) The role of EZH2 in the regulation of the activity of matrix metalloproteinases in prostate cancer cells. PLoS One 7(1):e30393

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Travis WD, Brambilla E, Muller-Hermelink HK et al (2004) World Health Organisation Classification of Tumors. Pathology and Genetics of tumors of the lung. Thymus and Heart, p 1

  29. van Leenders GJ, Dukers D, Hessels D, van den Kieboom SW, Hulsbergen CA, Witjes JA et al (2007) Poly-comb-group oncogenes EZH2, BMI1, and RING1 are over-expressed in prostate cancer with adverse pathologic and clinical features. Eur Urol 52(2):455–463

    Article  PubMed  Google Scholar 

  30. Wang Y, Fei M, Cheng C, Zhang D, Lu J, He S et al (2008) Jun activation domain-binding protein 1 negatively regulate p27 kip1 in non-Hodgkin’s lymphomas. Cancer Biol Ther 7(3):460–467

    Article  PubMed  Google Scholar 

  31. Wang Y, Yang S, Ni Q, He S, Zhao Y, Yuan Q et al (2012) Over-expression of forkhead box J2 can decrease the migration of breast cancer cells. J Cell Biochem 113(8):2729–2737

    Article  CAS  PubMed  Google Scholar 

  32. Watanabe H, Soejima K, Yasuda H, Kawada I, Nakachi I, Yoda S et al (2008) Deregulation of histone lysine methyltransferases contributes to oncogenic transformation of human bronchoepithelial cells. Cancer Cell Int 8:15

    Article  PubMed Central  PubMed  Google Scholar 

  33. Xu X, Yamamoto H, Sakon M, Yasui M, Ngan CY, Fukunaga H et al (2003) Over-expression of CDC25A phosphatase is associated with hyper-growth activity and poor prognosis of human hepatocellular carcinomas. Clin Cancer Res 9(5):1764–1772

    CAS  PubMed  Google Scholar 

  34. Zhang Y, Peng C, Wu G, Wang Y, Liu R, Yang S et al (2011) Expression of NLK and its potential effect in ovarian cancer chemotherapy. Int J Gynecol Cancer 21(8):1380–1387

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the National Natural Scientific Foundation of China (no. 81272708).

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Guoxin Mao or Qun Xue.

Additional information

Yiqun Zhou and Chunhua Wan contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhou, Y., Wan, C., Liu, Y. et al. Polycomb Group Oncogene RING1 is Over-expressed in Non-Small Cell Lung Cancer. Pathol. Oncol. Res. 20, 549–556 (2014). https://doi.org/10.1007/s12253-013-9727-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-013-9727-9

Keywords

Navigation